Madrigal Pharmaceuticals receives three new resmetirom patents

Go back to Madrigal Pharmaceuticals receives three new resmetirom patents
(NASDAQ: MDGL) Delayed: 519.78 -2.18 (0.42%)
Previous Close $521.96    52 Week High $18.24 
Open $525.77    52 Week Low $6.60 
Day High $528.42    P/E N/A 
Day Low $516.62    EPS $0.00 
Volume 90,470